# OnCo record paper-relativity-047-nejm-evid-2023-update (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-relativity-047-nejm-evid-2023-update/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-relativity-047-nejm-evid-2023-update" ;
  schema:name "Overall Survival and Response with Nivolumab and Relatlimab in Advanced Melanoma"@en ;
  schema:description "Later report from the RELATIVITY-047 trial registered as NCT03470922, in NEJM Evidence (2023); its title describes an updated or longer-term analysis."@en ;
  schema:url <https://onco.cc/key-papers/paper-relativity-047-nejm-evid-2023-update/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://doi.org/10.1056/evidoa2200239>, <https://pubmed.ncbi.nlm.nih.gov/38320023/>, <https://europepmc.org/article/MED/38320023>, <https://clinicaltrials.gov/study/NCT03470922> ;
  onco:tag "europepmc-ingest" ;
  schema:sameAs <https://doi.org/10.1056/evidoa2200239> ;
  schema:datePublished "2023"^^xsd:gYear ;
  schema:author "Long GV, Stephen Hodi F, Lipson EJ, et al." ;
  onco:trials <https://onco.cc/trials/relativity-047/> ;
  onco:journals <https://onco.cc/journals/nejm-evidence/> .